Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-02-02 @ 7:19 AM
Study NCT ID:
NCT01503450
Status:
COMPLETED
Last Update Posted:
2012-01-05
First Post:
2012-01-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
Sponsor:
Dr. Reddy's Laboratories Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Fed | View |
Keywords: